期刊文献+

2型糖尿病合并终末期肾病外周血CD_(34)^+细胞水平的临床研究 被引量:1

Clinical study on the changes of CD_(34)^+ cells in patients with type 2 diabetes mellitus complicated by terminal stage nephropathy
下载PDF
导出
摘要 目的分析CD+34细胞与糖尿病肾病代谢参数的相关性及其与糖尿病肾病发病的关系。方法选择终末期肾病患者100例,根据是否合并2型糖尿病分为合并糖尿病的终末期肾病组(n=55),为终末期肾病组(n=45)。糖尿病组(n=50)。同时选取体检中心健康体检者作为健康对照组(n=60)。比较4组三酰甘油(TG)、胆固醇(TC)、空腹血糖(FPG)、餐后2 h血糖(2 h FPG)、糖化血红蛋白(Hb A1c)、CD+34细胞/单核细胞值,尿微量白蛋白、肌酐(Cr)水平测定,肾小球滤过率的差异,以及各指标间的相关性。结果与阴性健康对照组比较,3个试验组CD+34细胞在单核细胞中的比值降低(P<0.05);糖尿病组高于终末期肾病组、糖尿病合并终末期肾病组(P<0.05)。糖尿病合并终末期肾病组外周血CD+34/单核细胞值与HBA1c、Cr、FPG、微量白蛋白、2 h FPG呈负相关(r值分别为-0.439、-0.241、-0.298、-0.342、-0.447,P<0.05)。结论 CD+34细胞可能是肾病患者的危险因素,参与肾病的发生,监测CD+34细胞水平变化也许能用来预测2型糖尿病患者合并终末期肾病的发生发展,其中糖尿病可能进一步导致CD+34细胞数量的下降。 Objective To analyze the correlation between CD34^+ cells and the parameters of diabetic nephropathy as well as the pathogenesis of diabetic nephropathy.Methods One hundred patients with terminal stage nephropathy were divided terminal stage nephropathy A group ( with diabetes, n =55 ) and terminal stage nephropathy B group ( without diabetes, n =45),simple diabetes group ( n =50),at the same time,60 healthy subjects were enrolled as control group.The TG,TC,FPG,2 hFPG,HbA1c,ratio of CD34^+ cells/monocytes,urine microcontent albumin,muscle anhydride levels,glomerular filtration rate were detected and comparted in the four groups.Results As compard with that in control group,the ratio of CD34^+ cells/monocytes in three experimental groups were obviously decreased ( P〈0.05 ) , which in diabetes group was significantly higher than that in terminal stage nephropathy A group and terminal stage nephropathy B group ( P〈0.05) .The ratio of CD34^+ cells/monocytes was negatively correlated to HbA1c, Cr, FPG in terminal stage nephropathy A group ( r =-0.439,-0.241,-0.241,-0.342,-0.298,respectively, P〈0.05).Conclusion CD34^+ cells may be risk factors for patients with diabetic nephropathy, which may be involved in the pathiogenesis of diabetic nephropathy, so monitoring the changes of CD34^+ cells may predict the pathogenesis and development of type 2 diabetes mellitus complicated by terminal stage nephropathy,in which diabetes mellitus may result in further decrease of CD34^+ cells.
出处 《河北医药》 CAS 2014年第23期3531-3534,共4页 Hebei Medical Journal
关键词 CD34^+细胞 2型糖尿病 终末期肾病 CD+34 cells type 2 diabetes mellitus terminal stage nephropathy
  • 相关文献

参考文献20

  • 1Garg AX, Kibexd BA, Clark WF, et al. Albuminufia and renalinsufficien- cy prevalence guides population screening: results from the NHANESⅢ. Kindney Int ,2002,61:2165-2175.
  • 2Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney dis- ease in the United States. JAMA,2007,298:2038-2047.
  • 3Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol,2003, 14:S131-138.
  • 4Kunitosbi I, Kentaro K, Atsushi S, et al. Changes in the demographics and prevalence of chronic kidney disease in Okinawa. Japan( 1993 to 2003 ). Hypertens Res ,2007,30:55-62.
  • 5Xue JL, Ma JZ, Louis TA, et al. Forecast of the number of patientswith end-stage renal disease in the United States to the year 2010. JAm Soc Nephrol, 2001,12 : 2753 -2758.
  • 6Ati AS, Remuzzi G. Chronic renal diseases as a public health problem: Epidemiology, social, and economic implications. Kidney Int, 2005,68 : 7- 10.
  • 7National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis ,2002,39 : S1 -S266.
  • 8Zuo L,Ma CHY, Wang M, et al. Application of glomernlar filtration rate estimating equations in chinses with chronic kidneydisease. Am J Kidney Dis ,2005,45:463-472.
  • 9Cepeda FJ, Fernandez E, Pobes A, et al. Utility of eystatin-C in hospital- ized patients. Comparing with diferent methods of assessing renal func- tion. Nefrologia, 2007,27 : 168 -174.
  • 10Yang YS, Peng CH, Liu CK, et al. Use of serum eystatin C to detect Ear- ly- decline of glomernlar filtration rate in type 2 diabetes. Intern Med,2007,46:801-806.

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部